Swissquote Bank Ltd., Switzerland’s leading online bank, announces the launch of a set of investor tools that help anticipate the impact of the French presidential election on financial markets. A key element is the Social Media Opinion Index, created in cooperation with the Social Media Lab at École polytechnique fédérale de Lausanne (EPFL).
The Index makes use of the latest advances in artificial intelligence to collect and analyze opinions about the candidates in the French election as expressed on social media networks; it allows investors to take the pulse of public online opinion about the candidates, indicating potential outcomes of the elections in real-time.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8083151-french-election-swissquote-epfl-investors/
Swissquote Bank Ltd., Switzerland’s leading online bank, announces the launch of investment options based on the possible victory of either candidate in the upcoming second round of the French presidential election. Investors can choose among baskets filled with stocks, indices and currencies, optimized for one of the two outcomes.
The stocks, indices and currencies in the two Macron baskets are expected to rise following a Macron victory; those in the Le Pen baskets would gain value with a Le Pen victory.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8095251-french-election-the-final-two/
Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology.
BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
Cancer takes more children’s lives than any other disease in the U.S., and nearly 25,000 kids will be diagnosed during the month of September alone. As the largest private funder of childhood cancer research grants, the St. Baldrick’s Foundation is on a mission to take childhood back from cancer by raising critical dollars for lifesaving research and spreading awareness about the harsh realities of childhood cancer.
This September, in recognition of Childhood Cancer Awareness Month, St. Baldrick’s will show how the research it funds is accelerating the development of new therapies and cures for kids with cancer everywhere. The Foundation will also share stories of kids affected by cancer – kids like David and Hazel who were both diagnosed with neuroblastoma, but faced two different outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/7916553-st-baldricks-childhood-cancer-awareness-month/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
According to recent survey by Medicomp Systems, 43 percent of healthcare IT professionals and physicians cited that their top data-related challenge was not a lack of data but rather the struggle to access the right data at the right time. Those findings aren't surprising since the vast majority of health information systems today share a common design flaw: they don't think and work the way physicians do at the point of care. However, they are still deeply concerning.
To deliver the best patient care, physicians need clinically relevant data that is seamlessly presented within their current workflows and integrated into the same workspace. The result is not only better patient care and better outcomes but also higher clinical effectiveness, efficiency, and satisfaction.
To view the multimedia release go to:
https://www.multivu.com/players/English/8189651-medicomp-systems-ebook-healthcare-data-challenges/
A profile of Smile Train, the world’s largest cleft organization, kicks off the 22nd season of The Visionaries, an award-winning public television series, hosted by acclaimed actor Sam Waterston. The Visionaries documentary series highlights the stories of individuals and nonprofit organizations that are working to create positive social change throughout the world. Visionaries has selected Smile Train to be profiled because the organization’s impact represents a unique opportunity to explore the seldom discussed issue of “appearance” in human society.
The Visionaries series takes viewers around the world to experience the lives of extraordinary people tackling some of humanity’s toughest challenges. The series guides viewers on a journey that leads to real solutions with proven outcomes, many of which have the potential to change the world.
To view the multimedia release go to:
https://www.multivu.com/players/English/8293751-smile-train-the-visionaries-documentary-pbs-series/
